|
|
||||||||
Ann Thorac Surg 2006;82:657-663
© 2006 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts
b Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Accepted for publication March 15, 2006.
* Address correspondence to Dr Sellke, Division of Cardiothoracic Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Suite 2A, Boston, MA 02215. (Email: fsellke{at}bidmc.harvard.edu).
BACKGROUND: Stromal-derived factor-1
(SDF-1
) binds to its specific receptor, CXCR4, and plays an important role in ischemia-induced angiogenesis. Some of the effects of SDF-1
are likely due to effects on the microcirculation. Cardioplegia and cardiopulmonary bypass (CP/CPB) activate mitogen-activated protein kinase (MAPK) signaling pathways including p38, ERK1/2, and JNK. The purpose of the present study was to evaluate SDF-1
expression, and relationships between SDF-1
-mediated coronary microvessel response and MAPKs.
METHODS: The atrial tissue of patients undergoing cardiac surgery was harvested before and after CP/CPB. Protein levels of SDF-1
and CXCR4 were measured by Western blot and immunohistochemistry, and plasma levels of SDF-1
were measured by enzyme-linked immunosorbent assay. Coronary microvessel responses to SDF-1
were assessed by videomicroscopy. To further elucidate SDF-1
/CXCR4 signaling, microvessel responses were evaluated in the presence of CXCR4 antagonist (AMD3100) and MAPK inhibitors, ERK1/2 inhibitor (UO126), p38 inhibitor (SB203580), and JNK inhibitor (ALX-159-600).
RESULTS: Myocardial protein expression of SDF-1
was elevated after CP/CPB (9.5 ± 3.5-fold, p = 0.03 versus before CP/CPB). Increases in SDF-1
spatially localized to endothelial cells, smooth muscle cells, and myocytes. Plasma levels of SDF-1
were increased after CP/CPB (3.2 ± 2.8 versus 2.8 ± 1.7 ng /mL, p = 0.03 versus before CP/CPB). Stromal-derived factor-1
induced coronary microvessel contraction after CP/CPB (p = 0.046 versus before CP/CPB), which was blocked by the CXCR4 antagonist. Furthermore, SDF-1
induced microvessel contraction was inhibited by MAPK inhibitors, ERK-1/2 (p = 0.046), p38 (p = 0.049), and JNK inhibition (p = 0.06).
CONCLUSIONS: These results suggest that CP/CPB induces myocardial expression of SDF-1
and results in coronary microvessel contraction through MAPK signaling pathways.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |